Clinical Trials Logo

Post-Operative States clinical trials

View clinical trials related to Post-Operative States.

Filter by:
  • None
  • Page 1

NCT ID: NCT00303433 Terminated - Delirium Clinical Trials

Namenda to Prevent Post-Operative Delirium

Start date: March 2006
Phase: Phase 4
Study type: Interventional

Post Operative Delirium is a common and serious risk of surgery. Delirium, when it occurs is associated with an increased risk of mortality, increase length of stay, and more adverse outcomes in general, including increased risk of higher level of care required at discharge. Namenda, which is currently approved for moderate or severe Alzheimer's disease has a unique mechanism of action than other drugs for this condition. It may have the ability to protect the brain from more severe consequences of hypoxia, or hypoglycemia. Hence it is being looked at in this study to see if it can reduce the incidence and/or severity of delirium post-operatively.